PG
Peter J Grua
Director

Peter J Grua insider trades: Evolent Health (EVH) stock buys and sales

Director, Evolent Health Last trade Mar 6, 2025 76 Form 4 filings
$0
Sold, last 12 months
0 sales
$0
Bought, last 12 months
0 buys
10
Open-market trades
since 2005
9
Companies
last trade 2025

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where Peter reports to the SEC

and 3 more companies

Open-market buys and sales

10 trades reported on SEC Form 4, newest first

DateStockTypeValue
Mar 6, 2025EVH↑ Buy$99K
Dec 17, 2019PHR↓ Sell$53.4M
Jul 22, 2019PHR↓ Sell$9.7M
Aug 16, 2016ABCO↓ Sell$104K
Nov 13, 2013TNDM↑ Buy$3.0M
May 28, 2013ABCO↓ Sell$101K
Aug 13, 2012ABCO↓ Sell$841K
May 7, 2012ABCO↓ Sell$931K
Sep 30, 2005DMAX↑ Buy$5K
Jul 22, 2005HCN↓ Sell$251K

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

Other EVH insiders

Open-market trades in the last 12 months

About Peter J Grua's insider trades

Peter J Grua is a director at Evolent Health (EVH). Since Jul 22, 2005, Peter has reported 3 open-market purchases worth $3.1M and 7 sales worth $65.4M on SEC Form 4. There have been no open-market trades in the last 12 months.

Their filings also include grants and awards (35 filings), option exercises (28 filings), other transactions (6 filings), gifts (4 filings). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every EVH insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.